BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 31037767)

  • 21. Identification of biomarkers correlated with diagnosis and prognosis of endometrial cancer using bioinformatics analysis.
    Zhao H; Jiang A; Yu M; Bao H
    J Cell Biochem; 2020 Dec; 121(12):4908-4921. PubMed ID: 32692884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis.
    Lv S; Xu X; Wu Z
    Oncol Lett; 2019 Dec; 18(6):6679-6689. PubMed ID: 31807178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Expression Significance of AKT1 by Co-expression Network Analysis in Endometrial Cancer.
    Huo X; Sun H; Liu Q; Ma X; Peng P; Yu M; Zhang Y; Cao D; Shen K
    Front Oncol; 2019; 9():1147. PubMed ID: 31781484
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of key genes and pathways between type I and type II endometrial cancer using bioinformatics analysis.
    Zhang K; Li H; Yan Y; Zang Y; Li K; Wang Y; Xue F
    Oncol Lett; 2019 Sep; 18(3):2464-2476. PubMed ID: 31452737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ZBTB7A, a potential biomarker for prognosis and immune infiltrates, inhibits progression of endometrial cancer based on bioinformatics analysis and experiments.
    Geng R; Zheng Y; Zhou D; Li Q; Li R; Guo X
    Cancer Cell Int; 2020 Nov; 20(1):542. PubMed ID: 33292231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer.
    Li Y; Li L
    BMC Genet; 2020 Sep; 21(1):113. PubMed ID: 32962636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the Role of Telomere and Telomerase Associated Genes and Proteins in Endometrial Cancer.
    Bradfield A; Button L; Drury J; Green DC; Hill CJ; Hapangama DK
    Methods Protoc; 2020 Sep; 3(3):. PubMed ID: 32899298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
    Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
    Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioinformatics Analysis of Global Proteomic and Phosphoproteomic Data Sets Revealed Activation of NEK2 and AURKA in Cancers.
    Deb B; Sengupta P; Sambath J; Kumar P
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-omics profiling reveals distinct microenvironment characterization of endometrial cancer.
    Cai Y; Chang Y; Liu Y
    Biomed Pharmacother; 2019 Oct; 118():109244. PubMed ID: 31352239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the circular RNA transcriptome in the grade 3 endometrial cancer.
    Ye F; Tang QL; Ma F; Cai L; Chen M; Ran XX; Wang XY; Jiang XF
    Cancer Manag Res; 2019; 11():6215-6227. PubMed ID: 31308756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data.
    Huo X; Sun H; Cao D; Yang J; Peng P; Yu M; Shen K
    Sci Rep; 2019 Jul; 9(1):9924. PubMed ID: 31289358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Potential Crucial Genes Associated With the Pathogenesis and Prognosis of Endometrial Cancer.
    Liu L; Lin J; He H
    Front Genet; 2019; 10():373. PubMed ID: 31105744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Potentially Novel Molecular Targets of Endometrial Cancer Using a Non-Biased Proteomic Approach.
    Taylor AH; Konje JC; Ayakannu T
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of E2F1 in the proliferation, migration, and invasion of endometrial carcinoma cells via the regulation of BMI1 transcription.
    Lu Y; Wei Y; Shen X; Tong Y; Lu J; Zhang Y; Ma Y; Zhang R
    Genes Genomics; 2023 Nov; 45(11):1423-1431. PubMed ID: 37646913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excavation of Molecular Subtypes of Endometrial Cancer Based on DNA Methylation.
    Liu Y; Gu Y; Zhang M; Zeng J; Wang Y; Wang H; Liu X; Liu S; Wang Z; Wang Y; Wang L; Zhang Y
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial cell-specific molecule 1 (ESM1) promoted by transcription factor SPI1 acts as an oncogene to modulate the malignant phenotype of endometrial cancer.
    He Y; Lin L; Ou Y; Hu X; Xu C; Wang C
    Open Med (Wars); 2022; 17(1):1376-1389. PubMed ID: 36117773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of prognostic long intergenic non-coding RNAs as competing endogenous RNAs with KRAS mutations in colorectal cancer.
    Xu J; Huang QY; Ge CJ
    Oncol Lett; 2021 Oct; 22(4):717. PubMed ID: 34429757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel Transcription Factor-Based Prognostic Signature in Endometrial Cancer: Establishment and Validation.
    Yang X; Cheng Y; Li X; Zhou J; Dong Y; Shen B; Zhao L; Wang J
    Onco Targets Ther; 2021; 14():2579-2598. PubMed ID: 33880037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advancement of E2F1 in Common Tumors].
    Shen C; Li J; Chang S; Che G
    Zhongguo Fei Ai Za Zhi; 2020 Oct; 23(10):921-926. PubMed ID: 33070516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.